The Cancer Research Foundation Prof. Dr. Gerhard Domagk, or Gerhard Domagk Foundation for short, in cooperation with the University Medicine Münster Foundation, awards the Gerhard Domagk Prize nationwide. This prize, endowed with 10,000 Euros, recognises scientific achievements that have made significant contributions to cancer research. Currently, the award is granted every two years. The application deadline is in October/November each cycle. The next award ceremony is planned for 2026.

• Video: Gerhard Domagk

• The Gerhard-Domagk-Prize 2024/25 was awarded on 10.09.2025 to:
  Prof. Dr. med. Frederik Damm
  Chief Senior Physician, Director of the Molecular Cancer Research Center (MKFZ), Charité – Campus Virchow‑Klinikum
  for the publication:
  Aggressive Lymphoma after CD19 CAR T-Cell Therapy
   
• not awarded in 2023
   
• The Gerhard-Domagk-Prize 2022 was awarded on 31.03.2023 to:
  Dr. Inés Garces de los Fayos Alonso
  Postdoctoral researcher at the Clinical Institute of Pathology, Medical University of Vienna.
  for the publication:
  PDGFRβ promotes oncogenic progression via STAT3/STAT5 hyperactivation in anaplastic large cell lymphoma
   
• The Gerhard-Domagk-Prize 2021 was awarded on 10.07.2022 to:
  Univ.-Prof.in Dr. Dr. Rebekka Schneider-Kramann
  Professor and Director, Institute of Cell and Tumor Biology, RWTH Aachen University
  for the publication:
  Heterogeneous bone marrow stromal progenitors drive myelofibrosis via a druggable alarmin axis
   
• The Gerhard-Domagk-Prize 2020 was awarded on 05.03.2021 to:
  Univ.-Prof. Dr. med. Viktor Grünwald
  Specialist in Internal Medicine, Hematology and Oncology at the University Hospital Essen.
  for the publication:
  Randomized Comparison of Pazopanib and Doxorubicin as First-Line Treatment in Patients With Metastatic Soft Tissue Sarcoma Age 60 Years or Older: Results of a German Intergroup Study
   
• The Gerhard-Domagk-Prize 2019 was awarded on 05.03.2021 to:
  Priv.-Doz. Dr. Philipp Vollmuth (geb. Kickingereder)
  Specialist in Radiology in the Department of Neuroradiology at the University Hospital Heidelberg.
  for the publication:
  Automated quantitative tumour response assessment of MRI in neuro-oncology with artificial neural networks: a multicenter, retrospective study.
   
• The Gerhard-Domagk-Prize 2018 was awarded on 14.12.2018 to:
  Univ.-Prof. Dr. med. David Capper
  Professor of Molecular Neuropathology at the Institute of Neuropathology, Charité – University Medicine Berlin.
  for the publication:
  DNA methylation-based classification of central nervous system tumours.
   
• The Gerhard-Domagk-Prize 2017 was awarded to:
  Univ.-Prof. Dr. med. Christoph A. Klein
  Head of the Institute for Experimental Medicine and Therapy Research at the University Hospital Regensburg.
  for the publication:
  Early dissemination seeds metastasis in breast cancer.
   
• The Gerhard-Domagk-Prize 2016 was awarded to:
  Univ.-Prof. Dr. med. Matthias Fischer
  Extraordinary (apl.) Professor in Pediatric Hematology and Oncology at the University Hospital Cologne
  for the publication:
  Telomerase activation by genomic rearrangements in high-risk neuroblastoma
   
• The Gerhard-Domagk-Prize 2015 was awarded to:
  Dr. med. Thomas Grünwald
  Medical staff member at the Institute of Pathology, Ludwig Maximilian University of Munich
  for the publication:
  Chimeric EWSR1-FLI1 regulates the Ewing sarcoma susceptibility gene EGR2 via a GGAA microsatellite.
   
• The Gerhard-Domagk-Prize 2014 was awarded to:
  PD Dr. med. Daniel Nowak
  Senior physician (attending) in hematology and oncology at University Medicine Mannheim.
  for the publication: 
  Myelodysplatic cells in patients reprogram mesenchymal stromal cells to establish a transplantable stem cell niche disease unit.